GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $16,857,000 | +73.1% | 100,000 | 0.0% | 0.02% | +50.0% |
Q4 2018 | $9,739,000 | -43.6% | 100,000 | 0.0% | 0.01% | -30.0% |
Q3 2018 | $17,274,000 | +23.8% | 100,000 | 0.0% | 0.02% | +17.6% |
Q2 2018 | $13,954,000 | +23.8% | 100,000 | 0.0% | 0.02% | +21.4% |
Q1 2018 | $11,267,000 | -52.2% | 100,000 | -44.0% | 0.01% | -50.0% |
Q4 2017 | $23,555,000 | +132.1% | 178,430 | +78.4% | 0.03% | +133.3% |
Q3 2017 | $10,149,000 | +1.2% | 100,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $10,025,000 | -17.1% | 100,000 | 0.0% | 0.01% | -20.0% |
Q1 2017 | $12,094,000 | +8.2% | 100,000 | 0.0% | 0.02% | +7.1% |
Q4 2016 | $11,175,000 | -15.8% | 100,000 | 0.0% | 0.01% | -17.6% |
Q3 2016 | $13,273,000 | +44.9% | 100,000 | 0.0% | 0.02% | +41.7% |
Q2 2016 | $9,157,000 | +26.9% | 100,000 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $7,215,000 | -48.0% | 100,000 | -50.0% | 0.01% | +11.1% |
Q4 2015 | $13,888,000 | +52.0% | 200,000 | -83.3% | 0.01% | -25.0% |
Q3 2015 | $9,137,000 | -25.6% | 1,200,000 | +1100.0% | 0.01% | -14.3% |
Q2 2015 | $12,284,000 | – | 100,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |